Correction to Lancet Oncol 2017; 18: 732-42

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2017 Aug.

. 2017 Aug;18(8):e433.

doi: 10.1016/S1470-2045(17)30527-2. Epub 2017 Jul 26.

No abstract available

Erratum for

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Diéras V, Miles D, Verma S, Pegram M, Welslau M, Baselga J, Krop IE, Blackwell K, Hoersch S, Xu J, Green M, Gianni L. Diéras V, et al. Lancet Oncol. 2017 Jun;18(6):732-742. doi: 10.1016/S1470-2045(17)30312-1. Epub 2017 May 16. Lancet Oncol. 2017. PMID: 28526536 Free PMC article. Clinical Trial.